2008 | 2007 | 2006 | 2005 |  2004 | 2003 |  2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | AllPubMed

Publications - 2008

Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Dal Pan GJ, Shriver Z, Langer RS, Venkataraman G, Austen KF, Woodcock J, Sasisekharan R. “Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System.” N Engl J Med 2008 Jun 5;358(23):2457-67

Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J, Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, and Sasisekharan R. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 2008 Jun;26(6):669-75

Srinivasan, A., Viswanathan, K., Raman, R., Chandrasekharan, A., Raguram, S., Tumpey, TM, Sasisekharan, V. and Sasisekharan, R. (2008) Quantitative Biochemical Rationale for Differences in Transmissibility of 1918 Pandemic Influenza A Viruses. Proc Natl Acad Sci USA 2008 Feb 26;105(8):2800-5

Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V & Sasisekharan R Glycan topology determines human adaptation of avian H5N1 virus hemagglutin Nat Biotechnol 2008 Jan;26(1):107-13

Packer NH, von der Lieth CW, Aoki-Kinoshita KF, Lebrilla CB, Paulson JC, Raman R, Rudd P, Sasisekharan R, Taniguchi N, York WS Frontiers in glycomics: Bioinformatics and biomarkers in disease. Proteomics 2008 Jan;8(1):8-20.

Last Updated: May 12, 2008